» Authors » Michael Magnussen

Michael Magnussen

Explore the profile of Michael Magnussen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maniou E, Todros S, Urciuolo A, Moulding D, Magnussen M, Ampartzidis I, et al.
Nat Mater . 2024 Jul; 23(11):1575-1581. PMID: 38969783
Morphogenesis requires embryonic cells to generate forces and perform mechanical work to shape their tissues. Incorrect functioning of these force fields can lead to congenital malformations. Understanding these dynamic processes...
2.
Urciuolo A, Giobbe G, Dong Y, Michielin F, Brandolino L, Magnussen M, et al.
Nat Commun . 2023 May; 14(1):3128. PMID: 37253730
Three-dimensional hydrogel-based organ-like cultures can be applied to study development, regeneration, and disease in vitro. However, the control of engineered hydrogel composition, mechanical properties and geometrical constraints tends to be...
3.
Contato A, Gagliano O, Magnussen M, Giomo M, Elvassore N
Front Bioeng Biotechnol . 2022 Aug; 10:871867. PMID: 36032711
In the last two decades lab-on-chip models, specifically heart-on-chip, have been developed as promising technologies for recapitulating physiological environments suitable for studies of drug and environmental effects on either human...
4.
Urciuolo A, Poli I, Brandolino L, Raffa P, Scattolini V, Laterza C, et al.
Nat Biomed Eng . 2020 Jun; 4(9):901-915. PMID: 32572195
Fabrication of three-dimensional (3D) structures and functional tissues directly in live animals would enable minimally invasive surgical techniques for organ repair or reconstruction. Here, we show that 3D cell-laden photosensitive...
5.
Martewicz S, Magnussen M, Elvassore N
Front Physiol . 2020 May; 11:384. PMID: 32390874
Non-genetic cardiac pathologies develop as an aftermath of extracellular stress-conditions. Nevertheless, the response to pathological stimuli depends deeply on intracellular factors such as physiological state and complex genetic backgrounds. Without...
6.
Leon T, Rapoz-DSilva T, Bertoli C, Rahman S, Magnussen M, Philip B, et al.
Cancer Discov . 2020 May; 10(7):998-1017. PMID: 32349972
Loss-of-function mutations of , the enzymatic component of PRC2, have been associated with poor outcome and chemotherapy resistance in T-cell acute lymphoblastic leukemia (T-ALL). Using isogenic T-ALL cells, with and...
7.
Rahman S, Magnussen M, Leon T, Farah N, Li Z, Abraham B, et al.
Blood . 2017 Mar; 129(24):3221-3226. PMID: 28270453
Somatic mutations within noncoding genomic regions that aberrantly activate oncogenes have remained poorly characterized. Here we describe recurrent activating intronic mutations of , a prominent oncogene in T-cell acute lymphoblastic...